IP Library Granted Patent US 8,032,346
Granted Patent B1
US 8,032,346 · App. 11/726,396 · Granted Oct 4, 2011

System and method for high-content oncology assay

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,032,346
App. No.
11/726,396
Granted
Oct 4, 2011
Kind
B1
Abstract

The present invention provides an apparatus, system, method and computer program and computer program product for analyzing cellular samples. One embodiment of the apparatus and method provides a multiparameter assay that provides information with respect to cell proliferation, cell cycling and cell death. The multiparameter assay is particularly useful for assessing and screening candidate compounds for anti-cancer utility.

Claims (24)

1. A method comprising:

comparing total nuclear brightness to standard deviation of nuclear brightness of a cell to produce a coordinate, and

determining the cell cycle phase of said cell using said coordinate.

2. The method of claim 1 , wherein said determining comprises filtering said coordinate.

3. The method of claim 2 , wherein said determining comprises filtering said coordinate through a plurality of filters, each of which defines coordinates corresponding to specific phases of the cell cycle.

4. The method of claim 1 , wherein said determining includes plotting said coordinate on a graph showing total nuclear brightness verses standard deviation of nuclear brightness of a population of cells.

5. The method of claim 1 , wherein said cell is a cell of a population of cells.

6. The method of claim 1 , wherein said method further comprises contacting said cell with a candidate agent prior to said comparing.

7. The method of claim 1 , wherein said cell is stained.

8. The method of claim 7 , wherein said cell is stained with a luminescent molecule that binds DNA.

9. The method of claim 1 , wherein said method is computer implemented.

10. A method comprising:

a) contacting population of cells with candidate agent;

b) analyzing cells of said population by:

i. comparing total nuclear brightness of a cell to standard deviation of nuclear brightness of said cell to produce a coordinate, and

ii. determining the cell cycle phase of said cell using said coordinate; and

c) detecting cells that have altered cell cycle phase.

11. A computer storage medium comprising:

computer executable instructions for:

comparing total nuclear brightness to standard deviation of nuclear brightness of a cell to produce a coordinate, and

determining the cell cycle phase of said cell using said coordinate.

12. A computer comprising a computer storage medium comprising computer executable instructions for:

comparing total nuclear brightness to standard deviation of nuclear brightness of a cell to produce a coordinate, and

determining the cell cycle phase of said cell using said coordinate.

Assignments (2)
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2007
From: CATALANO, SUSAN; MCLAUGHLIN, JOHN
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 019633/0039 →